| Literature DB >> 12857987 |
Hooman Noorchashm1, Siri A Greeley, Ali Naji.
Abstract
The present review highlights the two areas of research pursuit in our laboratory: (1). the regulation of the autoimmune T cell response to pancreatic islet beta cells using the nonobese diabetic (NOD) mouse model of type 1 diabetes and (2). the regulation the T cell response to alloantigens. Our work has established a central role for B lymphocytes in driving both autoimmune and allo-immmune T cell responses. Our studies indicate that: (1). B cell-deficient NOD mice are protected from autoimmune diabetes; (2). targeted disruption of cognate T/B cell collaboration via major histocompatibility complex (MHC) class II prevents both T cell-mediated islet destruction and allograft rejection; and (3). maternal transmission of islet-reactive autoantibodies potentiates the activation of diabetogenic T cells, highlighting the important role of B cells in the early targeting of islet beta cells.Entities:
Mesh:
Year: 2003 PMID: 12857987 DOI: 10.1385/IR:27:2-3:443
Source DB: PubMed Journal: Immunol Res ISSN: 0257-277X Impact factor: 2.829